Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
<p>Cisplatin is a widely used chemotherapeutic agent for treatment of various cancers. However, treatment with cisplatin is associated with drug resistance and several adverse side effects such as nephrotoxicity, reduced immunity towards infections and hearing loss. A Combination of cisplatin...
محفوظ في:
| المؤلف الرئيسي: | Iman W. Achkar (4246141) (author) |
|---|---|
| مؤلفون آخرون: | Nabeel Abdulrahman (725914) (author), Hend Al-Sulaiti (14153271) (author), Jensa Mariam Joseph (14151351) (author), Shahab Uddin (154400) (author), Fatima Mraiche (14151369) (author) |
| منشور في: |
2018
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted
حسب: Reem Ali (9913494)
منشور في: (2022) -
Characterization of the Cytotoxic Mechanism and Mode of Cell Death Induced by a MEK1/2-selective version of Anthrax Lethal Toxin (PrAg/LFW271A) in Acute Myeloid Leukemia
حسب: Mroue, Zeinab
منشور في: (2023) -
Targeting the MAP Kinase pathway in human acute myeloid leukemia cells using a recombinant anthrax lethal toxin. (c2013)
حسب: Kassab, Elias
منشور في: (2013) -
Characterization of the Potency and Mechanism of Action of a Novel Dual-Selective Intermolecularly Complemented Version of Anthrax Lethal Toxin (PAU2R200A- PAL1I207R/FP59) in Breast Cancer
حسب: Basala, Sobhiya
منشور في: (2023) -
Natural resorcylic acid lactones: A chemical biology approach for anticancer activity
حسب: Shilpa, Kuttikrishnan
منشور في: (2022)